market research report : cardiac pacemaker market in india 2013
DESCRIPTION
For the complete report, get in touch with us at : [email protected] Cardiac Pacemaker Market inIndiais expected to grow at a healthy rate as people are becoming more aware and cardiac pacemakers are also becoming more user friendly with added features. Also, cardiac pacemakers have become more affordable helping the market to grow even further.TRANSCRIPT
Executive Summary
MarketCardiac pacemaker market in India is growing at a CAGR of A % over 20‐‐‐‐‐e (volume wise)
The industry is dominated by foreign companies
Hospitals sell pacemakers as well as offer complete packages to patients
Drivers &
Drivers:
Changing demographics
High rate of cardiovascular diseases
L k i
Challenges:
Lack of standard regulatory structure and government initiatives
Challenges Low market penetration
Growing awareness
Changing Insurance coverage structure and business model
Unwillingness to spend on medical devices
Weak manufacturing base
TrendsProduct innovation
Focus on low cost goods
Significant presence of MNCs
Competitive Landscape
Majority of players in the cardiac pacemaker market are foreign companies with distributors and subsidiaries in India
Due to lack of a structured regulation, entry of more players is inhibited
2CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
LandscapeMajor players include A, B, C
•Macroeconomic Indicators
•IntroductionIntroduction
•Market Overview
I t E t•Import‐Export
•Drivers & Challenges
•Trends
•Competitive LandscapeCompetitive Landscape
•Strategic Recommendations
A di
3CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
•Appendix
Economic Indicators (2/3)
Gross Fiscal Deficit: Monthly
600
500
FE
C500
400
300
200
100
D
C
B
A
Exchange Rate: Half Yearly
100
0Feb‐‐Jan‐‐Dec‐‐Nov‐‐Oct‐‐Sep‐‐
g y
56 Q
53
54
55 YTR
E
W
4CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
52Jan ‐‐Dec ‐‐Nov ‐‐Oct ‐‐Sep ‐‐Aug ‐‐
Cardiac pacemaker market is poised to grow at a steady rate in the future
• Cardiac pacemaker market is expected to grow
steadily and offers strong potential for both existing
Market Overview (1/3) Market Size & Growth (Volume wise)
40
‘
A% FE
and new players
• Country A along with Country B are the growing
markets for cardiac rhythm management products of
which pacemakers form the largest part10
20
30E
DCBA
which pacemakers form the largest part
•Majority of players are foreign companies with
distributors or subsidiaries in India
These companies have been able to strengthen their
f h ld i h k d h i b d i i
020‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐
Market Size & Growth (Value wise)foothold in the market due to their brand recognition,
reliability and technological superiority
• Domestic players make significant investments and
rely on profits generated in India as well as abroad2
3
4
5 YTREWQ
B%
While some players purely operate in India, others have
global presence
Smaller players utilize product differentiation strategies
rather than reduced pricing methods to maintain their
f th ld i th k tHealthy growth rates provide an impetus to existing
0
1
2
20‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐
5CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
foothold in the market y g p p g
and potential players to invest in the market
Indian pacemaker market is heavily dependent on imports from the developed countries, but…
•The Government of India has always liberally allowed the import of medical electronic equipments
Imports – Overview Import of Cardiac Pacemakers
1,500 80O
Basic custom duty on pacemakers is S %
•Over the years, import of pacemakers has been steadily increasing
• Imports are mostly from the developed countries like 500
1,000
20
40
60PM
N
p y pA and country B
•Weak manufacturing base in responsible for imports
Import (Region Wise: 20‐‐)
0 020‐‐‐‐‐20‐‐‐‐‐ 20‐‐‐‐‐20‐‐‐‐‐
Import (Region Wise: 20‐‐)
c
C t CCountry BCountry A
b
d ce
C t H
Country FCountry G
de
f
a
b
OthersCountry ECountry DCountry C
a
f b Country H
OthersCountry JCountry I
6CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
Note: Figures are for respective financial years
a
Drivers & Challenges – Summary
Drivers Challenges
Lack of standard regulatory structureChanging demographics
High rate of cardiovascular diseases
Lack of standard regulatory structure and government initiatives
Unwillingness to spend on medical devices
Low market penetration
Growing awareness
Weak manufacturing base
Changing Insurance coverage structure and business model
7CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
Trends – Summary
Improvements in TechnologyTechnology
MarketCh i iCharacteristics
Monitoring via Internet ReuseMonitoring via Internet Reuse
8CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
Public: Domestic Company – Company A(1/4)Company Information Offices and Centres – India
Corporate AddressStreet AMaharashtra
T l N 91 22 12345678Tel No. +91‐22‐12345678
Fax No. +91‐22‐12345679
Website www.xyz.com
Year of Incorporation 19‐‐
Products and Services
Place A
Head Office
Incorporation
Ticker Symbol ‐‐
Stock Exchange BSE
Key People
Products and Services
Category Products/Services
CardiacPacemakers, Leads, Pacing System Analyzer
N D i tiOthers Dental Implants
Name Designation
Mr A MD
Mr B CEO
9CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
i i l S h K i
Public: Domestic Company – Company A(2/4)Financial Snapshot Key Ratios
Particulars y‐o‐y change (2012‐11)
2012 2011 2010 2009
Profitability RatiosOperating Margin
Net Profit/LossTotal Income
Net MarginProfit Before Tax MarginReturn on EquityReturn on Capital EmployedReturn on Working CapitalReturn on Assets20--20--20--20--
Financial Summary
• The company incurred a net loss of INR ‐‐ bn in FY 2012, as compared to net loss of INR ‐‐ bn in FY 2011
• The company reported total income of INR ‐‐ bn in FY 2012, registering an increase of % over FY 2011
Return on Fixed Assets
Cost RatiosOperating costs (% of Sales)Administration costs (% of Sales)
Interest costs (% of Sales)registering an increase of ‐‐% over FY 2011
• The company earned an operating margin of ‐‐% in FY 2012, an increase of ‐‐ percentage points over FY 2011
• The company reported debt to equity ratio of ‐‐ in FY 2012, an increase of ‐‐% over FY 2011
Interest costs (% of Sales)
Liquidity RatiosCurrent RatioCash Ratio
Leverage RatiosDebt to Equity Ratio
b i l iKey Financial Performance Indicators
Indicators Value (‐‐/‐‐/2013)Market Capitalization (INR mn) ‐‐Total Enterprise Value (INR mn) ‐‐EPS (INR)
Debt to Capital RatioInterest Coverage Ratio
Efficiency RatiosFixed Asset TurnoverAsset TurnoverCurrent Asset Turnover
10
EPS (INR) ‐‐PE Ratio (Absolute) ‐‐
Working Capital TurnoverCapital Employed Turnover
Improved Decline
CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
Public: Domestic Company – Company A(3/4)Key Business Segments Key Geographic Segments
100%
Product A
100%
Country BCountry A
0%
50%
100%
0%
50%
100%
H
G
F
E
D
C
B
ATotal revenue for the company comes this
segment for last K years
Business Highlights
0%20‐‐
0%
20‐‐20‐‐20‐‐20‐‐
Description News
Overview • Operates with its subsidiary, ABC Limited
Business• It has its plant located at Area 1, State XYZ • Has a licensed and installed capacity of producing B pacemakers annually• The company is also into the business of contract manufacturing
Pacemakers• They make both internal as well as external pacemakers• The permanent pacemakers are available in various modes such as : Multi Programmable, Non‐programmable, dual chamber, rate responsive and bifocal
Shareholders • Promoters occupy S % of the shares whereas general public hold G % of the shares
11CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
Shareholders • Promoters occupy S % of the shares whereas general public hold G % of the shares
Awards and Recognitions • Received type A certification in 20‐‐
Public: Domestic Company – Company A(4/4)
•G•H
• I• J
S WS W
TO TO •D•E•F
•A•B•C
12CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
Appendix
Ratio Calculations
Operating Margin (Operating Income/Revenues)*100
Ratio Calculations
Current RatioCurrent Assets / Current Liabilities
Net Margin (Net Profit / Revenues) *100
Profit Before Tax Margin (Income Before Tax / Revenues *100
(N I / Sh h ld
Cash Ratio{(Cash & Bank Balance + Marketable Securities) / Current Liabilities)}
Debt to Equity Total Liabilities / Shareholders E it
Return on Equity (ROE) (Net Income / Shareholders Equity)*100
Return on Capital (ROCE) EBIT / (Total Assets – Current Liabilities)*100
q yEquity
Debt to Capital Ratio{Total Debt / (Shareholders Equity + Total Debt)}
Interest Coverage Ratio EBIT / Interest Expense
Return on Working Capital (EBIT / Working Capital) *100
Return on Assets (EBIT / Total Assets)*100
Return on Fixed Assets (EBIT / Fixed Assets) *100
Fixed Asset Turnover Sales / Fixed Assets
Asset Turnover Sales / Total Assets
Operating Costs (% of Sales) (Operating Expenses / Sales) *100
Administration Costs (% of Sales)
(Administrative Expenses / Sales) *100
Current Asset Turnover Sales / Current Assets
Working Capital Turnover Sales / Working Capital
Sales / (Shareholders Equity +
13CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
Interest Costs (% of Sales) (Interest Expenses / Sales) *100 Capital Employed Turnover Sales / (Shareholders Equity + Total Debt)
Thank you for the attentionThe Cardiac Pacemaker Market India 2013 report is part of Netscribes, Inc. Healthcare Series.For any queries or customized research requirements, contact us at:
Phone: +91 33 4027 6214/6215
Follow us on:
Phone: 91 33 4027 6214/6215E‐Mail: [email protected]
About Netscribes, Inc.Netscribes, Inc. is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of , g g f g p y p p finvestment & business research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one‐stop shop designed to fulfil clients’ profitability and growth objectives.
Disclaimer: This report is published for general information only Although high standards have been used in the preparation “Netscribes” is
14CARDIAC PACEMAKER MARKET IN INDIA 2013.PPT
Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction.